A New Look at Heath-Care Reform by Weidenbaum, Murray L
Washington University in St. Louis 
Washington University Open Scholarship 
Murray Weidenbaum Publications Weidenbaum Center on the Economy, Government, and Public Policy 
Occasional Paper 148 
2-1-1995 
A New Look at Heath-Care Reform 
Murray L. Weidenbaum 
Washington University in St Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/mlw_papers 
 Part of the Economics Commons, and the Public Policy Commons 
Recommended Citation 
Weidenbaum, Murray L., "A New Look at Heath-Care Reform", Occasional Paper 148, 1995, doi:10.7936/
K72F7KM3. 
Murray Weidenbaum Publications, https://openscholarship.wustl.edu/mlw_papers/136. 
Weidenbaum Center on the Economy, Government, and Public Policy — Washington University in St. Louis 
Campus Box 1027, St. Louis, MO 63130. 
Center for 




NOT FOR RELEASE BEFORE 
9:00A.M. PST 
FEBRUARY 9, 1995 
A New Look at Health-Care 
Reform 
Murray Weidenbaum 
Occasional Paper 148 
February 1995 
Contact: Ron Cook 
Media Associ ate 
(314) 935-5630 
Washington University Campus Box 1208 One Brookings Drive St. Louis. Missouri 63130-4899 
A New Look at Health-Care Reform 
Murray Weidenbaum 
The time is ripe for taking a new look at health-care reform. Clearly, conventional 
approaches have bogged down in the legislative process. A fresh start is necessary. To begin, 
truly reforming the health-care delivery system of the United States requires developing a 
sensible and sensitive mechanism to balance the demand for health care with its supply. That is 
the only effective way of dealing simultaneously with the powerful demand for medical 
services, the limited resources available, and the pressures of rising costs and prices. 
Managed competition may help, but it will not suffice. Instituting global budget caps 
or otherwise attempting to restrain medical care prices is not workable for any extended length 
of time. As with all forms of price controls, such a bureaucratic approach merely postpones 
the difficult decisions to another time. It still leaves unanswered the vital question of how the 
now unrestrained level of health-care demand is to be met and paid for. 
I put aside the question of lack of universal health-insurance coverage - and for good 
reason. My justification for doing so is that most public discussions equate lack of insurance 
with lack of medical care. That is just erroneous. A large array of health-care providers does 
give medical services - at low or no cost - to those without insurance. To be sure, often the 
result is inefficient, such as the excessive use of emergency rooms. But, to clear the air, we 
must note that is just a special case of a problem that I will be dealing with - people 
demanding expensive health care without paying the full cost. 
One complication is curable. At present, employees - or their employers acting in 
their behalf - cannot buy a modest health-care plan. State insurance commissions dictate the 
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composition of these plans and they are very amenable to lobbying by special interests. Thus, 
in many states, the plans must include hair transplants, acupuncture, and other inherently 
optional items. In effect, the purchaser of health insurance cannot buy a Ford. It must be a 
Lincoln- or nothing. As Voltaire said it, "the best is the enemy of the good." Of course, this 
is not a federal case. Each state insurance commission should shift its focus from serving the 
special interests among health-care providers to meeting the needs of the patients. 
The Two Basic Alternatives 
Let us begin with the fundamentals. There is a spectrum of possible responses to the 
health-care dilemma, each with its own set of advantages and disadvantages. 
The Free-Market Approach 
At the free-market end of the policy spectrum is an approach based on each family (or 
unattached individual) making their own choices on what type of medical outlays they will 
request - and pay for. This means a general elimination of third-party payments and a 
restoration of the traditional producer-consumer relationship which is found in most, but not 
all, other product and service markets. 
Indeed, the primary reliance on third-party payments is a relatively recent phenomenon 
- which reminds us that the present pattern can be changed. Third-party payments have 
become increasingly important only in the last several decades. Back in 1960, people paid 49 
percent of their health-care costs, while government agencies paid 24 percent and insurance 
companies paid 22 percent. A complete reversal has occurred in the intervening years. By 
1993, people paid less than 18 percent of their medical costs. The lion's share was borne by 
government (44 percent) and insurance (34 percent). For hospital service, as an example, the 
patient now pays only 3 percent. For doctor bills, the average patient payment is 15 percent of 
the total. 
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The implication of the shift to "third-party" financing of health care cannot be 
overestimated. Important evidence comes from an experiment by the non-profit Rand 
Corporation. For a few years, thousands of families in the experiment were given one of four 
health insurance plans. The difference between the plans was the co-payment rate, that is, the 
portion of health expenses paid by the family. The co-payment rate varied from 0 to 95 
percent. Under all the plans, if a family's out-of-pocket expenses reached $1,000, the 
insurance paid for all additional expenses. 
The experiment's main finding was that the higher a family's co-payment rate, the less 
often members of that family went to a doctor and the less often they incurred medical expenses 
generally. In the words of my colleague David R. Henderson, "people do consume more 
health care when they are spending other people's money." Interestingly, the Rand experiment 
found no substantial improvement in health outcomes for the higher spending by the families 
with low co-payment rates. 
Relying on the marketplace is the self-policing way to control medical costs. When 
patients pay the bills directly, they become cost conscious - and so do the people and 
organizations serving them. The market approach differs fundamentally from the typical 
"third-party" payments so widely used in the United States. Under this latter method, patients 
usually do not know the prices and costs of their medical care before hand, if ever. 
In the United States, third parties that pay the bills have effectively removed the patient 
from the traditional consumer role of watchdog. Rarely are prices of physician and hospital 
services or goods such as prescription drugs advertised to consumers. Economist Rita Ricardo-
Campbell and her associates state the matter quite bluntly: 
When patients become concerned about prices (because they pay the bills directly), 
physicians will become concerned about costs. . . . The only way to lower the cost of 
medical care in this country, and simultaneously maintain a high level of quality, is to 
give medical-care consumers the incentive to worry about prices. 
Of course, there always were important exceptions to the operation of the free market 
in health care. Modem society has never been willing to accept the full consequences of 
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allocating medical care solely on the desire and ability to pay. To economists, this signified 
that health care was a "merit want," meaning that society wanted a bit more supplied than 
resulted simply from the operation of market forces. However, in this approach, market forces 
are supplemented, not supplanted. Destitute- or just poor people- receive free or low-cost 
medical treatment, although sometimes of a lower quality than the rest of the society and 
usually at greater inconvenience. 
Primary reliance on the market means that the price system effectively rations the 
amount of health care produced and consumed. As a practical matter, that amount is likely to 
be considerably less than the results of current policy. A sensible step toward the free-market 
approach would be to reduce the various governmental subsidies which increase people's 
demand for the "best" health-care service. A good place to begin is to eliminate the tax 
advantage now given to health care over other consumer expenditures. Specifically, employer-
financed health insurance should be included in taxable employee compensation along with 
direct payments of wages and salaries. Few people recall that the popularization of employer-
financed insurance plans and other fringe benefits occurred during World War II as a loophole 
to get around wage controls. The special tax treatment is not justified by any canon of 
efficiency or fairness and should be eliminated. 
Furthermore, much of the formal effort to "economize" on health-care costs by 
departing from marketplace competition is illusory. A major example is the cost shifting under 
Medicaid (and to a lesser extent, Medicare). That does little to reduce the nation's total 
medical outlays. That procedure mainly forces other patients to pay for a portion of health care 
for the elderly. The effects of the large "purchasing pools" are often quite similar and 
especially devastating to the smaller enterprises which are excluded. However, sometimes the 
activities of the purchasing pools do force some serious economies of operation. 
To some significant extent, private health plans - goaded by employers who are 
unhappy at the steady stream of premium increases- can try to weed out high-cost providers, 
to limit the use of expensive specialists, to monitor closely the performance of health-care 
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providers, and to emphasize preventative care. As we will see, such pressures are becoming 
increasingly effective. They can be reinforced, however, by giving employees a similar stake 
in controlling health-insurance premiums. 
The Governmental Approach 
At the other end of the policy spectrum is the notion that the society should finance 
whatever level of healtlr 1re is required by each citizen. This general notion is embodied in 
. ;j: 
the "single payer" plan. whereby- at least in theory- government simply pays everyone's 
health bills. That may be the basis on which this plan can be sold, but practical problems 
abound. When health care becomes a free good, the individual response quickly becomes 
"Nothing's too good for me if I don't have to pay for it." 
Because human wants are insatiable, the notion that each of us is entitled to all the 
medical care that we ask for exhausts the ability of even the most generous source of financing. 
Therefore, in practice, each single player plan adopts or reluctantly backs into some form of 
rationing. One of the most widely used means of limiting care is oblique or indirect. It is the 
bureaucratic technique of delay and inconvenience. I refer to the queue - forcing people to 
wait longer than they now do before they receive medical services, including having to go 
through a variety of reviews or "gatekeeper" approvals. For example, it has been said of some 
high-risk surgical procedures under the Canadian system that the patient is more likely to die 
while waiting his or her tum than on the operating table. On average, it takes nine months for 
a hip replacement. 
Rationing by delay appeals to the bureaucratic instinct. It does not require making 
many difficult decisions. It is easy to administer. The queue even sounds fair: first come, first 
served. But, rationing by delay distributes the benefits of limited care in a very arbitrary 
manner. At the policy level, relying on the queue does require making some difficult choices 
in terms of determining the supply of the various treatments that are available. Just as the free-
6 
market approach in practice is supplemented by free or low-cost care, the "health as a free 
good" approach is usually supplemented by a limited free market. 
A safety valve often accompanies the queue approach. However, it favors upper 
income individuals or at least people who value health care highly enough to pay for it. 
Wealthy Canadians, for example, come to the United States for serious surgery when they are 
not content with the quality or the time availability of the health care provided in Canada. 
Under the Clinton plan, even such a safety valve would have been restricted or prohibited. 
One of the claimed benefits of the single-payer approach could be achieved without 
resorting to a massive expansion of the government's role. A standard medical card for each 
person with the vital personal and insurance infonnation would avoid the repetitious collection 
of the same data by each health-care provider. The transcription errors which occur so 
frequently would be avoided, as well as the delays bedeviling patients and medical offices alike. 
Surely, in this electronic age, the paperwork burden could be reduced substantially. 
Voluntary cooperation on the part of key private associations - the American Medical 
Association, the American Hospital Association, the American Phannaceutical Association, etc. 
-should be able to accomplish this useful change. 
Along these lines, the Quincy Foundation for Medical Research has proposed the 
establishment of a network of computer tenninals located at care delivery sites. Each 
participant in the program would receive a code card containing his or her social security 
number and basic personal data. Other infonnation could be included, such as medical status. 
We can endorse this portion of the Quincy Foundation proposal without embracing the notion 
of using the medical card to administer eligibility for a variety of governmentally imposed 
benefits. More recently, Congress's Office of Technology Assessment has urged the 
standardization of insurance claim fonns and electronic submission and payment of insurance 
claims as other ways of using infonnation technology to curb health-care costs. The French 
have pioneered card technology in health care and claim to be saving substantially on 
administrative costs. 
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All in all, it seems unlikely that - at least in the near future - public policy will adopt 
either of the two extremes that I have just presented. Yet, it is useful to view the various 
individual proposals in terms of whether they move the health-care system toward the 
governmental pole or toward the individual choice pole . 
An Upbeat Outlook 
There is a natural tendency to look to government to correct the various shortcomings 
in our society. Health care, of course, is no exception to the search for reducing so-called 
market failures. However, over the years we have discovered the substantial presence of what 
can be called government failures - the disadvantages that often result when the public sector 
attempts to improve on the imperfect performance of the private sector. This line of reasoning 
does not support the arbitrary elimination of government activity. Rather, it injects a useful 
note of skepticism in the recurring debates over expanding the role of government in the 
economy. 
Along these lines, it is pertinent to note a separate and noteworthy development. While 
the Congress and the Clinton Administration have been debating inconclusively the various 
ways for the federal government to provide better health care, the institutions that actually 
provide medical care have been undergoing an unprecedented but voluntary restructuring. The 
health-care delivery system is being reformed. To a substantial degree, the marketplace is 
transforming itself and is delivering health care at reduced costs. Technically, the rate of price 
increases is slowing down more frequently than actual prices are turning down - but that is 
still an improvement over the previous trend. In Southern California, the Hospital Council 
reports that the incomes of medical specialists are "dropping like stones." 
The voluntary changes being made in health care are taking many forms. By the end 
of 1994, a majority of privately-insured Americans were enrolled in managed-care plans that 
limit choice of doctors and treatments. In California, three-fourths of all privately-insured 
8 
patients are now in Health Maintenance Organizations (HMOs). At least three-fourths of all 
physicians had signed contracts, covering at least some of their patients, to reduce their fees 
and to accept oversight of their medical decisions. About nine out of every ten doctors who 
work in group practices have agreed to such managed-care arrangements. 
Large insurance companies are setting up "community care" networks . They are 
acquiring hospitals and clinics, so that they can offer a full spectrum of treatment for a fixed 
price. In suburban Atlanta, Aetna has opened six primary care centers. In the same area, 
another large insurance company, Cigna, has acquired medical practices and is recruiting 
doctors for its own clinics. Ultimately, these conglomerates may include, in addition to 
insurance companies and hospitals, some of the following- outpatient clinics, doctors' offices, 
nursing homes, hospices, home health-care services, pharmacies, drug treatment centers, and 
medical equipment suppliers. 
The Michigan health-care network is a good example of the voluntary changes taking 
place. The network is vertically integrating the Henry Ford Health System, Mercy Health 
Services, and Michigan Blue Cross/Blue Shield. The network of 13 hospitals offers health care 
to groups of 100 employees or more. It requires a fixed monthly payment averaging $200 for 
an individual and $466 for a family. The Michigan network promises that premiums will not 
rise more than 5 percent in 1994 or 1995. Similarly, New York Hospital has established a 
regional alliance with seven other non-profit hospitals, two nursing homes, and four walk-in 
clinics. The latter send their most complicated cases to New York Hospital. 
Three large hospital alliances, created in the last two years, now care for about three-
fourths of the hospital patients in the St. Louis area. Each alliance is actively buying up the 
practices of primary-care physicians (those who refer patients to hospitals and other specialized 
services). 
In many communities, hospitals have been hiring or buying out the practices of 
primary-care doctors - family practitioners, general internists, and pediatricians - to assure a 
stream of patient referrals and to increase their bargaining power with insurance companies. 
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The South Carolina Medical Association has been developing an alternative approach. It is 
forming a statewide network of doctors to negotiate contracts with employers and take 
responsibility for controlling their health costs. Health-care networks already dominate 
Southern California. Hospitals, physicians, and insurance companies all have established 
health-care networks. Mullikin Medical Enterprises, which is owned by 200 physicians in 
Southern California, is acquiring the practices of other medical groups around the state. Solo 
practitioners are becoming rare. 
On a national scale, an unprecedented wave of mergers and acquisitions is occurring 
among major health-care providers. Columbia/RCA Healthcare, the country's largest for-
profit hospital chain (with more than 190 hospitals), has bought out Medical Care America, the 
largest chain of surgery centers and now accounts for about one-half of the for-profit hospital 
capacity in the United States. In contrast, Surgical Care Affiliates, which operates a chain of 
outpatient surgery centers, is luring patients away from hospitals. These centers provide a 
lower-cost setting for many of the less critical operations, such as removal of cataracts, 
tonsillectomies, and laparoscopic gallbladder removals. 
The large pharmaceutical companies - squeezed by national policy and regional 
health-care providers - have been actively diversifying within the health-care sector. Merck 
acquired Medea Containment, the managed-care drug distributor, for an impressive $6.6 
billion. SmithKline Beecham merged with Diversified Pharmaceutical, another managed-care 
drug marketer, in a $2.3 billion transaction. Eli Lilly paid $4 billion to buy PCS Health 
Systems, the largest company that processes payments for prescription drugs. In that instance, 
the Federal Trade Commission made its antitrust "clearance" contingent on assurances that 
patients using the drug benefit company would not be limited to Lilly products. In an unusual 
foray into providing health-care services, Zeneca Group, a manufacturer of cancer drugs, 
acquired 50 percent of Salick Healthcare, an operator of cancer care centers. In this segment 
of health care, a pattern of mergers and acquisitions is also evident. Thrifty Drug Stores 
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bought the Payless drugstores of Kmart. Revco acquired Hook-Supe Rx and Rite Aid 
purchased Perry Drug Stores. 
Meanwhile, many individually-owned pharmacies are finding that they lack the 
resources to compete for managed-care business and are becoming members of chains, 
franchises, and other group efforts . In the future, perhaps insurance companies and hospitals 
will get together. Between them, they have the large organizational skills and recordkeeping 
that are necessary. Hospitals have the patients and insurance companies have the market - the 
willingness of employers to pay for the health care of the employees. 
Stepping back from the concern with health care, important as it is , we have to raise 
several serious questions from the viewpoint of the structure of the American economy; Is the 
day of the small "business" in services over? Will the opportunities for cost reduction be 
translated into lower prices for the patient? So far, competition in the various parts of the 
health-care sector has been on the rise, thus advancing the cause of restraining health-care 
costs. Nevertheless, the future viability of new and small providers and the ultimate impact of 
the consumer remain open questions. 
Conclusions and Recommendations 
The operation of market forces often proceeds more rapidly and more effectively in 
responding to serious problems than do the more ponderous decisionmaking mechanisms of the 
public sector. Indeed, often the reduction of governmental impediments to competition 
represents the most efficient and least costly solution. Medical care is no exception to that 
basic proposition. 
The most effective driving force to slow the rapid rise in health-care costs is now the 
business firms who find that this special expense reduces their competitiveness in an 
increasingly global marketplace. The pressure they exert on their health-insurance carriers, in 
turn, is transmitted to health-care providers. As we have seen, hospitals, physicians, and 
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pharmaceutical firms have been engaged in an unprecedented effort tb restructure, streamline, 
diversify, and otherwise reduce their costs - while they maintain or expand their share of a 
rapidly and radically changing marketplace for health care. 
There is an important role for public policy in this important adjustment process, but it 
is not the role envisioned by most participants in the political process. To continue the 
movement to greater efficiency while meeting the needs of the consumer (i.e., the patient), it is 
necessary to further reduce the impediments to the fuller operation of competitive market 
forces. 
Surely, the most fundamental change needed is to reduce the dependence on third-party 
reimbursements. To the extent that patients view medical care as a "free" (or low-cost) good 
to them, the ability to contain costs will be greatly limited. It is basically unfair to maintain a 
situation where party A demands the "best" medical services and party B must find a way to 
pay for that largesse. 
For the typical middle class patient/consumer, it makes no sense to go through an 
insurance/reimbursement system for routine office and out-patient hospital visits and 
procedures. What is required is to stop looking at health insurance as a benefit or, worse yet, 
as an entitlement. Rather, each of us must consider health insurance as a form of insurance 
protecting us from chance but potentially devastating circumstances. The implication of that 
seemingly simplistic change is profound. 
Take automobile insurance as a basis for comparison. Each vehicle owner chooses a 
form of deductible. This means that many fender benders or paint scratches (the equivalent of 
the routine office visit) are not covered by insurance. There is no massive outcry that this 
approach is "unfair" to poor people. Motorists generally understand that a deductible is 
necessary to avoid swamping the insurance system with the paperwork that would push up 
premiums very sharply. As a result, of course, many paint scratches and dented fenders go 
unfixed - but that is the considered choice of the owners who would rather spend their money 
on something else. 
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Indeed, Dominion Resources, Inc ., a Virginia utility holding company, has moved in 
this direction. The company treats its health program like true insurance, reimbursing for 
insurable events rather than for routine medical expenditures. The plan is structured so that 
employees are reimbursed for a small number of large claims rather than a large number of 
small claims. Savings that result from shifting away from traditional health-care coverage are 
shared equally between the employer and the employees. 
The Dominion Resources approach seems in accord with the recent reminder by Martin 
Feldstein and Jonathan Gruber that the purpose of insurance is to protect individuals against 
unexpected expenses. An optimal insurance policy, in their view, involves balancing the gains 
from financial protection against the losses that result from the distortion of behavior toward 
excessive care induced by reducing the cost of treatment to the patient. 
Under the present array of public policies, primary reliance on third-party 
reimbursement strikes most taxpayers as highly desirable. First of all, not many of our fellow 
citizens are sophisticated enough to understand that such fringe benefits as employer-paid health 
insurance are a substitute for wages in the employee's compensation package. But even among 
the growing minority that comprehend the process, the status quo is still considered to be a 
good deal because wages and salaries are taxable income, while fringe benefits are not. 
The answer, of course, is to make the entire compensation package taxable, including 
employer-paid health-insurance premiums. That will not eliminate the demand for such 
fringes, even among the most sophisticated, for a variety of reasons. Some of these are 
eminently sensible, such as the desire to obtain the economies of scale that result in lower 
group rates for a given coverage than the rates charged to the individual or family who tries to 
deal directly with an insurance carrier. A level playing field in the taxation of compensation 
would not constitute a panacea but it surely will help. 
Many other changes in public policy would be helpful, especially to increase the 
knowledge available to consumers to enable them to make more informed choices. In one 
specific area - the purchase of pharmaceutical products - government policy now restricts or 
.· 
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prevents the ability of the patient even to acquire the basic information concerning the prices to 
be charged by different providers for the same or similar products. At the present time, many 
states prohibit advertising the price of prescription drugs. Such restrictions make it difficult for 
consumers to shop for the best price. Every state legislature which has enacted such anti-
consumer legislation should promptly repeal it. Even pharmaceutical industry critic Senator 
David Pryor (D-Ark.) has urged that the market for medicine be made more price sensitive. 
He specifically states, "Any reform effort should make sure that both doctors and patients are 
more aware of prices." 
At the federal level, the Food and Drug Administration should reduce the barriers it 
has set up that inhibit advertising prescription medicines. Because consumers must obtain a 
prescription from a physician in order to acquire prescription drugs, there is less reason to fear 
deception in advertising in this market than in any other. On the positive side, experience 
shows that direct advertising can reduce the prices that consumers pay. Such evidence was 
cited by the Supreme Court in the decision overturning state bans on advertising eyeglasses. 
The current FDA rules on advertising appear to be needlessly bureaucratic. 
Specifically, the agency should reconsider the requirement for the misnamed "brief summary" 
which must accompany any ad that both mentions a health condition and indicates the name of 
a drug which can be used for the condition. The notorious "brief summary" is actually a 
lengthy statement in small print listing side effects and contraindications associated with a 
prescription drug. Of course, such information is essential for physicians, for whom the brief 
summaries were originally designed. But, for the average patient, the technical language 
borders on the incomprehensible. 
The FDA regulations also discourage prescription drug ads from being shown on 
television, a major source of information for many consumers. The high cost of ads in the 
print media- resulting from the FDA requirements- also reduces their use. Like so much 
government regulation, the result is just the opposite of what the FDA says it wants. Due to 
the restraint on advertising, consumers may not be aware that a treatment exists for a certain 
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condition and so they will not consult a physician. In other circumstances, consumers may 
suffer some symptoms (e.g., thirst) without realizing that these are symptoms of a treatable 
disease (e.g., diabetes). Alternatively, a new remedy with reduced side effects may become 
available, but patients are not aware of it and do not visit their physicians to obtain a 
prescription. 
If there is any single conclusion that emerges from this presentation, it is that no single 
solution - no silver bullet - is available to cure all the ailments besetting the American health-
care system. What will help - and in a fundamental way - is to acknowledge that difficult 
choices have to be made among imperfect alternatives. I trust that the package of alternatives I 
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